ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
65.28
+0.06 (0.09%)
Jul 3, 2025, 1:00 PM - Market closed
ANI Pharmaceuticals Employees
ANI Pharmaceuticals had 897 employees as of December 31, 2024. The number of employees increased by 255 or 39.72% compared to the previous year.
Employees
897
Change (1Y)
255
Growth (1Y)
39.72%
Revenue / Employee
$751,469
Profits / Employee
-$25,008
Market Cap
1.31B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ANIP News
- 4 days ago - ANI Pharmaceuticals to Participate at Leerink Partners Therapeutics Forum: I&I and Metabolism on July 8th - GlobeNewsWire
- 24 days ago - ANI Pharmaceuticals Announces Presentation of New Preclinical Data - GlobeNewsWire
- 5 weeks ago - ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Benzinga
- 6 weeks ago - ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout Flares - GlobeNewsWire
- 7 weeks ago - ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ - GlobeNewsWire
- 2 months ago - ANI Pharmaceuticals, Inc. (ANIP) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance - GlobeNewsWire